Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1985 Jan 1;132(1):39–40.

Vancomycin-induced neutropenia.

R L Mackett, D R Guay
PMCID: PMC1346502  PMID: 3965060

Abstract

Although rare, neutropenia associated with long-term vancomycin therapy may occur. A 67-year-old woman with cellulitis and sepsis caused by Staphylococcus aureus was treated initially with cefazolin. Despite in-vitro susceptibility of the organism to this drug, the patient remained febrile, and therapy was changed to vancomycin. On day 17 of therapy with this medication neutropenia was noted; it progressed over the next 3 days, and therapy with the drug was stopped. A rise in the neutrophil count occurred within 5 days of discontinuation. Periodic monitoring of the leukocyte count during longterm vancomycin therapy is recommended.

Full text

PDF
39

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borland C. D., Farrar W. E. Reversible neutropenia from vancomycin. JAMA. 1979 Nov 30;242(22):2392–2393. [PubMed] [Google Scholar]
  2. Farber B. F., Moellering R. C., Jr Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother. 1983 Jan;23(1):138–141. doi: 10.1128/aac.23.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gopal V., Bisno A. L., Silverblatt F. J. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA. 1976 Oct 4;236(14):1604–1606. [PubMed] [Google Scholar]
  4. Hook E. W., 3rd, Johnson W. D., Jr Vancomycin therapy of bacterial endocarditis. Am J Med. 1978 Sep;65(3):411–415. doi: 10.1016/0002-9343(78)90766-0. [DOI] [PubMed] [Google Scholar]
  5. Kauffman C. A., Severance P. J., Silva J., Jr, Huard T. K. Neutropenia associated with vancomycin therapy. South Med J. 1982 Sep;75(9):1131–1133. doi: 10.1097/00007611-198209000-00029. [DOI] [PubMed] [Google Scholar]
  6. Kesarwala H. H., Rahill W. J., Amaram N. Vancomycin induced neutropenia. Lancet. 1981 Jun 27;1(8235):1423–1423. doi: 10.1016/s0140-6736(81)92598-8. [DOI] [PubMed] [Google Scholar]
  7. Strikas R., Studlo J., Venezio F. R., O'Keefe J. P. Vancomycin-induced neutropenia. J Infect Dis. 1982 Oct;146(4):575–575. doi: 10.1093/infdis/146.4.575. [DOI] [PubMed] [Google Scholar]
  8. Weitzman S. A., Stossel T. P. Drug-induced immunological neutropenia. Lancet. 1978 May 20;1(8073):1068–1072. doi: 10.1016/s0140-6736(78)90915-7. [DOI] [PubMed] [Google Scholar]
  9. West B. C. Vancomycin-induced neutropenia. South Med J. 1981 Oct;74(10):1255–1256. doi: 10.1097/00007611-198110000-00028. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES